Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Elvanse 30mg Hard Capsules

Active Ingredient:
lisdexamfetamine dimesylate
Company:  
Takeda UK Ltd See contact details
ATC code: 
N06BA12
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Elvanse - Chart for ongoing monitoring of lisdexamfetamine therapy - HCP

{healthcare_pro_orange} For Healthcare Professionals
Elvanse - Chart for ongoing monitoring of lisdexamfetamine therapy - HCP
{pdf_link}

Elvanse - Checklist 1: lisdexamfetamine checklist before prescribing - HCP

{healthcare_pro_orange} For Healthcare Professionals
Elvanse - Checklist 1: lisdexamfetamine checklist before prescribing - HCP
{pdf_link}

Elvanse - Checklist 2: checklist for ongoing monitoring of lisdexamfetamine therapy - HCP

{healthcare_pro_orange} For Healthcare Professionals
Elvanse - Checklist 2: checklist for ongoing monitoring of lisdexamfetamine therapy - HCP
{pdf_link}

Elvanse - potential for non-medical use & diversion of prescription stimulant medications - Pt

Elvanse - potential for non-medical use & diversion of prescription stimulant medications - Pt

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Takeda UK Ltd
Company image
Address
1 Kingdom Street, London, W2 6BD, UK
WWW
www.takeda.com/en-gb/
Telephone
+44 (0)3333 000 181
Medical Information e-mail
[email protected]
Drug Safety e-mail
[email protected]
Medical Information Direct Line
+44 (0)3333 000 181